The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease.

Raj, Desh; Tomar, Bhawna; Lahiri, Amit; Mulay, Shrikant R

Raj, Desh; Tomar, Bhawna; Lahiri, Amit; Mulay, Shrikant R.

Affiliation

Raj D; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India.
Tomar B; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Lahiri A; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India.
Mulay SR; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India. Electronic address: shrikant.mulay@cdri.res.in.

Pharmacol Res ; 152: 104617, 2020 02.

Article in En | MEDLINE | ID: mdl-31881272

Subject(s)

Fatty Liver/complications; Gastrointestinal Microbiome; Intestines; Kidney; Liver; Renal Insufficiency, Chronic/etiology; Animals; Fatty Liver/microbiology; Humans; Renal Insufficiency, Chronic/microbiology

Key words

CKD; Fibrosis; Gut microbiota; Gut-kidney axis; Gut-liver axis; Inflammation; Insulin resistance; Intestinal barrier integrity; Liver-kidney axis; NAFLD; NASH

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Renal Insufficiency, Chronic / Fatty Liver / Gastrointestinal Microbiome / Intestines / Kidney / Liver Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Pharmacol Res Year: 2020 Document type: Article

Fulltext

XML

PubMed Links

Search on Google